Status:
COMPLETED
Breast Cancer Risk Reduction: A Patient Doctor Intervention
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Susan G. Komen Breast Cancer Foundation
California Breast Cancer Research Program
Conditions:
Breast Cancer
Eligibility:
All Genders
40-74 years
Phase:
NA
Brief Summary
The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for wome...
Eligibility Criteria
Inclusion
- Patient component:
- Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
- Between the ages of 40 and 74
- Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
- Have no history of breast cancer are eligible to participate.
- Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF
Exclusion
- Patient component: Women whose physicians object to their participation in the study
- Physician component: No exclusion criteria for physicians
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
1235 Patients enrolled
Trial Details
Trial ID
NCT01830933
Start Date
June 1 2011
End Date
December 1 2012
Last Update
August 19 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hospital (SFGH)
San Francisco, California, United States, 94110
2
University of California, San Francisco Mt. Zion campus
San Francisco, California, United States, 94143